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Background: Molecular MRI is becoming increasingly important for preclinical
research. Validation of targeted gadolinium probes in tissue however has been
cumbersome up to now. Novel methodology to assess gadolinium distribution in
tissue after in vivo application is therefore needed..e00606
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
y-nc-nd/4.0/).
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Article Nowe00606Purpose: To establish combined Magnetic Resonance Imaging (MRI) and Mass
Spectrometry Imaging (MSI) for improved detection and quantiﬁcation of
Gadoﬂuorine P deposition in scar formation and myocardial remodeling.
Materials and methods: Animal studies were performed according to
institutionally approved protocols. Myocardial infarction was induced by
permanent ligation of the left ascending artery (LAD) in C57BL/6J mice. MRI
was performed at 7T at 1 week and 6 weeks after myocardial infarction.
Gadoﬂuorine P was used for dynamic T1 mapping of extracellular matrix
synthesis during myocardial healing and compared to Gd-DTPA. After in vivo
imaging contrast agent concentration as well as distribution in tissue were
validated and quantiﬁed by spatially resolved Matrix-Assisted Laser Desorption
Ionization (MALDI) MSI and Laser Ablation e Inductively Coupled Plasma e
Mass Spectrometry (LA-ICP-MS) imaging.
Results: Both Gadoﬂuorine P enhancement as well as local tissue content in the
myocardial scar were highest at 15 minutes post injection. R1 values increased
from 1 to 6 weeks after MI (1.62 s1 vs 2.68 s1, p ¼ 0.059) paralleled by an
increase in Gadoﬂuorine P concentration in the infarct from 0.019 mM at 1 week
to 0.028 mM at 6 weeks (p ¼ 0.048), whereas Gd-DTPA enhancement showed
no diﬀerences (3.95 s1 vs 3.47 s1, p ¼ 0.701). MALDI-MSI results were
corroborated by elemental LA-ICP-MS of Gadolinium in healthy and infarcted
myocardium. Histology conﬁrmed increased extracellular matrix synthesis at 6
weeks compared to 1 week.
Conclusion: Adding quantitative MSI to MR imaging enables a quantitative
validation of Gadoﬂuorine P distribution in the heart after MI for molecular
imaging.
Keywords: Biomedical engineering, Cardiology, Medical imaging
1. Introduction
Following ischemia, the left ventricular myocardium undergoes a series of changes
in geometry, function and biochemical adaptations. A collagen-rich extracellular
matrix is produced to replace lost cardiomyocytes in the infarct to form a stable
scar [1]. Successful infarct healing requires a balance between synthesis and degra-
dation of extracellular matrix to preserve cardiovascular function. Excessive extra-
cellular matrix (ECM) formation, both in the infarcted but also in the remote
myocardium, can result in increased wall stiﬀness and decline of compliance, sub-
sequently leading to diastolic dysfunction [2]. On the other hand, insuﬃcient pro-
duction of extracellular matrix components can lead to progressive thinning of the
myocardial wall and expansion of the infarcted area, with increased risk for lefton.2018.e00606
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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rupture [4, 5].
To better visualize ECM synthesis during myocardial healing and remodeling, more
speciﬁc and quantitative imaging methods are desirable. With the advent of molecular
contrast agents that bind to speciﬁc extracellular matrix proteins such as collagen [6,
7] or elastin [8], imaging of ECM remodeling has become feasible. Until recently
MRI was only used to generate weighted images (e.g. T1-weighting or T2-
weighting), which are not quantitative. T1 mapping, currently the most accurate
tool to quantify accumulation of gadolinium agents, provides reliable assessment of
gadolinium induced relaxation rate changes [9]. However, the imaging signal itself
may not directly correlate with the actual amount of the molecular gadolinium probe
in tissue, as the signal is inﬂuenced by a variety of additional factors of the local
microenvironment such as pH-levels, oxygenation, extra- and intracellular compart-
mentalization of the gadolinium molecules [10, 11]. Spatially-resolved quantiﬁcation
of gadolinium agents in tissue has not been possible until recently. Matrix Assisted
Laser Desorption Ionization - Mass Spectrometry Imaging (MALDI-MSI) can be
used to visualize and precisely quantify various gadolinium chelates in tissue sections
after the contrast agent has been applied in vivo [12]. Laser Ablation e Inductively
Coupled Plasma e Mass Spectrometry (LA-ICP-MS) imaging can achieve quantita-
tive resolution of gadolinium molecules in tissue almost at cellular resolution [13].
In the current study, we aim to combine MRI and MSI in a multiscale imaging
approach to quantitatively track Gadoﬂuorine P accumulation as a surrogate for
ECM concentration during myocardial healing and remodeling. We hypothesize
that Gadoﬂuorine P would enable us to follow the process of ECM deposition in
the infarct zone after experimental myocardial infarction, and that MSI provides
complementary spatial and quantitative information for molecular contrast agent
deposition.2. Materials and methods
2.1. Animal model
Myocardial infarction (MI) was performed in female C57BL/6J mice (aged 10e14
weeks, Charles River Laboratories, Sulzfeld, Germany) by permanent ligation of the
left anterior descending artery (LAD) as previously described [8]. MR kinetic studies
applying T1 mapping were performed in n ¼ 7 mice per time point for Gadoﬂuorine
P and Gd-DTPA as reference. The kinetic study for Gd-DTPA was performed over
120 minutes. After administration of Gadoﬂuorine P an additional measurement af-
ter 12 hours was performed due to the extended kinetic proﬁle. For the assessment of
extracellular matrix (ECM) synthesis over time MR imaging was performed either at
1 week and mice were sacriﬁced thereafter or at 1 and 6 weeks after myocardialon.2018.e00606
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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ment of the Gadoﬂuorine P concentration kinetics by MSI infarcted mice were inves-
tigated at 6 weeks post MI and animals were sacriﬁced at 8 min, 15 min, 21 min, 30
min, 40 min and 60 min after injection of the contrast agent. All animal experiments
were approved by the local subcommittee on Research Animal Care (Protocol Num-
ber 55.2-1-54-2532-85-13).2.2. Contrast agents
Gadoﬂourine P is a further derivative of Gadoﬂuorine M (Bayer Healthcare, Berlin,
Germany), an amphiphilic experimental MRI contrast agent, composed of a Gd-
DO3A derivative with a lysine linker, a hydrophilic sugar moiety (mannose) and
a perﬂuorinated lipophilic side chain, which has been shown to bind to collagen, pro-
teoglycans and tenascin in animal models of atherosclerosis [14]. The binding to-
wards extracellular matrix proteins is mainly due to an unspeciﬁc adsorption
towards proteins and ﬁlaments resulting from diﬀerent charge properties. Due to
the prolonged blood and tissue half-life and subsequent delayed excretion, Gado-
ﬂuorine M has been discontinued and modiﬁed by replacing the lysine backbone
with a shorter ethylendiamine linker and the sugar moiety by a short polyethylengly-
col unit, leading to the generation of Gadoﬂuorine P (invivoContrast GmbH, Berlin,
Germany). Chemical structure and mass spectrum showing the respective m/z at
1323.2 Da with the Gadolinium speciﬁc isotope pattern is shown in Fig. 1. Gado-
ﬂuorine P is an amphiphilic, iso-osmolar gadolinium agent with a plasma protein
binding of more than 90%, resulting in a plasma half-life in rats of about 2 hours.
Gadopentetate dimeglumine (Gd-DTPA, Bayer Healthcare, Berlin, Germany) was
used as an unspeciﬁc reference agent.2.3. MR imaging
Magnetic Resonance Imaging was performed on a horizontal bore 7T small animal
scanner (Disovery MR901, GE Healthcare, Chalfont St. Giles, United Kingdom)Fig. 1. Chemical structure and Mass spectrum of Gadoﬂuorine P. Chemical structure (A) and predicted
isotope pattern of Gadoﬂuorine P (B). For peak identiﬁcation, the mass spectra obtained from heart sec-
tions (C) were compared to the predicted isotope distribution pattern.
on.2018.e00606
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diameter 1H/13C quadrature birdcage resonator (Rapid Biomedical, Rimpar, Ger-
many). Image acquisition was performed under free-breathing conditions and pro-
spective ECG triggering (Rapid Biomedical, Rimpar, Germany). During imaging,
the animals’ temperature was maintained atz38 C using an MR-compatible heat-
ing system (Bruker Biospin, Ettlingen, Germany).
Both contrast agents were injected at a dose of 0.2 mmol kg1 body weight via the
tail vein. After determining a peak enhancement of Gadoﬂuorine P within the
myocardial scar at a time point of 15 minutes, imaging for subsequent experiments
was then routinely performed at 15 minutes after contrast agent injection. All scans
were acquired as short axis views. On the 3-plane scout scans a long axis scan was
planned as a ﬁrst step. In a second step a 4-chamber view was acquired. The short
axis views were planned perpendicular to the long axis view and 4-chamber view.
After selecting short-axis planes for Late gadolinium enhancement (LGE) assess-
ment, a segmented inversion-recovery fast gradient echo sequence was performed
using the following parameters: FOV 30  30 mm, matrix 192  192 (in-plane res-
olution 156 mm), slice thickness 1 mm, TR/TE/TI 7.6 ms/3.1 ms/350 ms, ﬂip angle
60, 4 k-space lines/RR interval, 2 scans, and 8 slices. After delayed enhancement
acquisition single-slice T1 mapping was performed in the same geometry in one
midventricular short axis slice with the largest extent of the infarcted myocardium
on LGE imaging. A standard inversion prepared prospectively ECG-gated Look-
Locker sequence was used. Speciﬁc sequence parameters were as followed: FOV
30  30 mm, matrix 128  128 (in-plane resolution 234 mm), slice thickness 1
mm, TR/TE 5.1 ms/1.3 ms, ﬂip angle 8, 4 lines/RR interval, 2 scans, total scan
time ca. 8 min. For T1 estimation, Look-Locker data analysis was performed using
an open-source software tool (MRmap v1.4) for the generation of relaxation time
maps in MRI [15]. T1 images were calculated from DICOM source images based
on a 3-parameter Levenberg-Marquardt curve ﬁtting procedure with a correction
for read-out-induced attenuation of the relaxation curve as described previously
[16]. Regions of interest (ROI) were drawn manually in the in the infarcted myocar-
dium and remote myocardium based on the LGE images and then copied to the T1
maps.
Cardiac function was determined by established CINE imaging. CINE images for
the assessment of cardiac function were acquired as a stack of 8 slices in the short
axis plane to cover the entire left ventricle. The CINE images were acquired in
each animal before the administration of the contrast agent. CINE acquisition was
synchronized with every R wave. Sequence parameters were: FOV 30  30 mm,
matrix 128  128 (in-plane resolution 234 mm), slice thickness 1 mm, TR/TE
2.77 ms/0.86 ms, ﬂip angle 30,4 scans. An average of 12 cardiac cycles was ac-
quired per slice. The ejection fraction was calculated from CINE images as followed:
[(End diastolic volume e End systolic volume)/End diastolic volume]  100.on.2018.e00606
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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MALDI combines extraction of molecules of interest via an overlying matrix with a
time of ﬂight approach to analyze ionized molecules depending on their mass,
respectively charge they generate once reaching the detector. The advantage of
MALDI is that the sample itself is not ablated, as it is the case with LA-ICP-MS,
and can thus be used further for histology/immunohistochemistry. Sectioning of
fresh frozen infarcted mouse hearts was performed as described previously [12].
Cryosections (12 mm thickness) were prepared and mounted onto conductive
Indium-Tin-Oxide (ITO) glass slides (Bruker Daltonik GmbH, Bremen, Germany),
which were pre-coated with 1:1 poly-L-lysine (Sigma-Aldrich, Taufkirchen, Ger-
many) and 0.1 % Nonidet P-40 (nonylphenoxylpolyethoxylethanol 40, Sigma-
Aldrich, Taufkirchen, Germany). Detection of Gadoﬂuorine P was optimized as
described previously. For quantiﬁcation of Gadoﬂuorine P signal, a standard curve
was prepared additionally for each slide. For this purpose, liver cryosections of un-
treated mice were mounted on the ITO slides and 0.5 ml Gadoﬂuorine P, diluted in
water to concentrations ranging from 0.5 to 0.01 mg/ml (0.3782 mMe0.0076 mM),
was spotted onto the liver sections. To obtain digital images for co-registration, heart
sections were dried at room temperature and scanned using a ﬂatbed scanner. Matrix
solution, composed of 7 g/l CHCA (Sigma-Aldrich, Taufkirchen, Germany) in 70%
methanol and 0.2% triﬂuoroacetic acid (TFA, Applied Biosystems, Darmstadt, Ger-
many) was applied using an ImagePrep spray device (Bruker Daltonik GmbH, Bre-
men, Germany). MALDI-TOF Imaging measurements were carried out at a spatial
resolution of 70 mm using an Ultraﬂex III MALDI TOF mass spectrometer (Bruker
Daltonik GmbH, Bremen, Germany) in positive reﬂector mode with a sampling rate
of 1.0 GS/s. A total of 200 laser shots were accumulated for each position measured.
After mass spectrometry measurements, the matrix was removed with 70% ethanol
and the sections were stained with an Elastica van Gieson stain (Morphisto GmbH,
Frankfurt am Main, Germany). Elastica van Gieson staining was applied to stain for
elastic ﬁbers and collagen ﬁbers. Speciﬁcally, the tissue is ﬁrst stained with a
Resorcin-Fuchsin-solution (also known as Weigert staining). Subsequently tissue
is stained with hematoxylin and after that counterstained with picrofucsin. Cell
nuclei appear as ebrown-black, elastic ﬁbers black-purple. Picrofucsin staining
adds a yellow-brown staining to the cytoplasm and red stain of the collageneous ﬁ-
bers. All stained slides were scanned at 20x objective magniﬁcation using a Mirax
Desk digital slide scanner (Carl Zeiss MicroImaging, Munich, Germany). For
each of the resulting digital slides, subsets (regions of interest) were deﬁned from
areas of myocardial infarction and analyzed using commercially available software
(Deﬁniens Enterprise Image Intelligence Suite, Deﬁniens AG, Munich, Germany). A
speciﬁc rule set was developed to detect and quantify the Elastica-van-Gieson
stained elastic ﬁbers and whitespaces within the tissue based on staining intensity,on.2018.e00606
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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whitespace in comparison to the total tissue area and the relative red staining inten-
sities of the elastic ﬁbers were calculated. Images were subsequently merged with the
mass spectrometry datasets. Data are presented as mean peak intensity.2.5. Laser ablation e inductively coupled plasma e mass
spectrometry (LA-ICP-MS)
While MALDI MSI is dependent on the overlying matrix and can only reach a
spatial resolution of w 50 mm, LA-ICP-MS does not require an overlying matrix
to extract molecules of interest and reaches a spatial resolution below 5mm - in
the cellular range. For analysis via LA-ICP-MS, cryosections (10 mm thickness)
were prepared with a cryomicrotome model CRYOSTAR NX70 (ThermoFisher Sci-
entiﬁc, Bremen, Germany) using TissueTek for ﬁxation and were mounted onto
glass slides (VWR, Darmstadt, Germany). For quantiﬁcation, matrix-matched stan-
dards based on gelatin (GR€USSING GmbH, Filsum, Germany) were prepared by
mixing 100 mg gelatin with 900 mL of Gd solutions ranging from 1 to 750 mg/L.
These matrix-matched standards were homogenized at 60 C and 10 mm cryosec-
tions were prepared.
To determine the Gd concentration of these standards, ICP-MS analysis was per-
formed. Therefore, 50 mg of gelatin standard were dissolved in 2% HNO3 and
diluted to ﬁnal concentrations ranging between 1 and 30 mg/L. All solutions con-
tained 1 mg/L Ho (1000 mg/L Ho, SCP Science, Quebec, Canada) as internal stan-
dard. Six Gadolinium standards ranging from 5 to 30 mg/L, prepared from ICP
standard (1000 mg/L Gd, Sigma-Aldrich, Taufkirchen, Germany) were used to
quantify the dissolved gelatin standards. The analyses were performed using an
ICP-MS instrument model iCAP Q (ThermoFisher Scientiﬁc, Bremen, Deutsch-
land) equipped with an ASX-560 autosampler, PFA Micro-Flow nebulizer, cyclonic
spray chamber, Ni sampler and Ni Skimmer.
Elemental imaging with LA-ICP-MS was performed with an ICP-MS instrument
model iCAP TQ (ThermoFisher Scientiﬁc, Bremen, Deutschland) with O2 as re-
action gas. Dwell times for the Gd isotopes between 0.07 and 0.1 s were used.
The samples were introduced with an LSX-213 G2þ laser ablation system (Teledyne
CETAC, Thousand Oaks, USA) including a HelEx II ablation cell and Helium as
transport gas.
The samples were ablated with a spot size between 15 and 40 mm and an adjusted
scan speed between 45 and 120 mm/s. Nine lines per gelatin standard were ablated
with the same parameters and the averaged intensities were used to quantify the Gd
content via external calibration. The isotope 158Gd was used for quantiﬁcation.on.2018.e00606
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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Values are presented as mean  standard deviation (SD) or dot plot diagrams with
mean and 95% conﬁdence interval. Comparison of measurements over time between
diﬀerent groups were performed using 2-way analysis of variance (ANOVA) fol-
lowed by Bonferroni post-hoc test for multiple comparisons. Comparison of values
obtained at one versus six weeks were performed using an unpaired student’s t-test
(two-tailed). Comparison of R1 values with LVEF was performed using Pearson’s
correlation. A p-value of <0.05 was considered statistically signiﬁcant.
An overview of the experiments with the according sample sizes is provided in
Fig. 2.3. Results
3.1. Enhancement kinetics of Gadoﬂuorine P compared to Gd-
DTPA
To evaluate the time course of Gadoﬂuorine P performance, a kinetic analysis of
contrast enhancement for Gd-DTPA and Gadoﬂuorine P was performed in the
infarcted myocardium over time. Imaging was performed at week 6 post infarctionFig. 2. Experimental overview. Course of experiments is provided together with the corresponding sam-
ple size, respectively mice used for each experiment.
on.2018.e00606
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15e20 minutes after injection and R1 values returned close to baseline at 100 mi-
nutes post injection. Highest R1 values were obtained within the blood, which is
attributed to the albumin binding capacity of Gadoﬂuorine P (Fig. 3).3.2. MALDI-MSI
Gadoﬂuorine P was successfully visualized by MALDI-MSI and the contrast agent
concentrations could be mapped onto the corresponding histology sections. Gado-
ﬂuorine P accumulated speciﬁcally within the infarct scar, whereas in the remote
myocardium only a fraction was detectable which was localized in the myocardial
vasculature (Fig. 4). Mean Gadoﬂuorine P concentration in the infarcted myocar-
dium peaked 15 minutes after i.v. injection (0,0224 mM). After 60 minutes the con-
centration in the infarcted myocardium reached the baseline (0,0069 mg/ml). The
concentration in remote myocardium was constant over the whole time period
(0,0069 mM 15 min p.i. to 0,0062 mM 60 min p.i.).3.3. Gadoﬂuorine P for assessment of postinfarction scar
formation
Toevaluate the use of ourmultiscale imaging approach for studyingmyocardial healing
and remodeling, we scanned the same mice at 1 and 6 weeks after LAD ligation using
Gadoﬂuorine P-enhancedMRI and sacriﬁcedmice at each time point forMALDI-MSI.
Reference Gd-DTPA measurements showed no signiﬁcant diﬀerences between R1
values in the infarctedmyocardium at 1 (3.95 1.5 s1) and 6 (3.47 2.26 s1) weeksFig. 3. Enhancement Kinetics after administration of contrast agents. In vivo MRI kinetic studies of
contrast enhancement show R1 values after intravenous Gd-DTPA (left panel), and Gadoﬂuorine P (right
panel) administration at a concentration of 0.2 mmol/kg body weight in the same mice (n ¼ 7). Measure-
ments with Gadoﬂuorine P were performed 24h after the measurements with Gd-DTPA. R1 values are
given for the area of myocardial infarction (Infarct), remote myocardium (Myocard) and blood (Blood
Pool). Mean values and SD for infarcted (þSD) and health myocardium (-SD) are shown. Gadoﬂuorine
P shows stable enhancement of the infarct scar for 15e40 minutes post injection.
on.2018.e00606
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Fig. 4. Kinetics of Gadoﬂuorine P by MALDI-MSI. Assessment of Gadoﬂuorine P kinetics at 15, 30 and
60 minutes after injection in Late Gadolinium Enhancement (LGE, left column), T1 maps (middle col-
umn) and MALDI-MSI fused with Elastica-Van-Gieson staining (EvG) (right column) are shown. Right
upper panel in ﬁrst LGE image depicts coronal view of the heart for better anatomic orientation, blue line
indicates the level of the transverse imaging planes shown in left and middle column (LV ¼ left ventricle,
LA ¼ left atrium). Infarct delineation was based on EvG histology (small panel in ﬁrst MALDI image).
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were higher at 6weeks afterMI (2.88 0.51 s1) compared to 1week (1.62 0.11 s1,
p¼ 0.0422). IncreasedR1 values at 6weekswere corroborated by increasedGadoﬂuor-
ine P concentrations observed by MALDI-MSI. Gadoﬂuorine P concentration was
signiﬁcantly higher (p ¼ 0.0479) in infarcted myocardium after 6 weeks (0.0283 
0.0038 mM) compared to the earlier time point at 1 week post MI (0.0198  0.0054
mM) (Fig. 5AeC). Interestingly, direct correlation of R1 values at 1 and 6 weeks
showed only amoderate correlation with the actual Gadoﬂuorine P concentration in tis-
sue, both for the infarct and remote myocardium (Fig. 5D and E).3.4. Gadolinium tissue analysis by elemental LA-ICP-MS
While MALDI-MSI provides probe assessment of molecular MR contrast agents,
LA-ICP-MS provides a fully quantitative analysis of gadolinium in tissue andon.2018.e00606
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Fig. 5. Gadoﬂuorine P enhancement at 1 and 6 weeks after myocardial infarction. A) Comparison of R1
values for Gd-DTPA and Gadoﬂuorine P at 1 and 6 weeks after myocardial infarction (n ¼ 5, scanned
subsequently on week 1 and 6). While Gd-DTPA enhancement does not change between 1 and 6 weeks
post MI, Gadoﬂuorine P induces increased R1 values at 6 compared to 1 week (p ¼ 0.0422). B) Gado-
ﬂuorine P concentration assessed by MALDI-MSI 1 and 6 weeks after myocardial infarction revealed
increased Gadoﬂuorine P uptake at 6 weeks (p ¼ 0.0479); n ¼ 5 mice for week 1 and n ¼ 5 for
week 6 (6 weeks mice same as Fig. 3A. C) Representative images of Gadoﬂuorine P accumulation in
myocardial infarction (MI) in vivo (T1 maps upper row) and ex vivo (MALDI-MSI fusion with EvG,
lower row) at 1 and 6 weeks after MI. MALDI-MSI images were obtained from the same mice as the
corresponding MR images. The inset T1 map (ﬁrst row in the upper left corner) shows the corresponding
T1 map of the same mouse obtained at 1 week compared to 6 weeks (ﬁrst row large panel on the right).
D) Correlation of R1 values (n ¼ 5 mice for each time point) in infarcted myocardium with Gadoﬂuorine
P concentration at 1 (r2 ¼ 0.37) and 6 (r2 ¼ 0,58) weeks after MI show only moderate correlations be-
tween contrast agent concentration and R1. E) Similarly, within the healthy myocardium correlation of R1
values in healthy myocardium with Gadoﬂuorine P concentration by MALDI-MSI at 1 (r2 ¼ 0.85) and 6
weeks (r2 ¼ 0.56) after MI show only moderate agreement. * indicates p-value < 0.05.
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chose to additionally analyze tissue samples by LA-ICP-MS. LA-ICP-MS provided
quantiﬁcation of Gd in infarcted mouse hearts at a resolution of down to 15 mm
(Fig. 6A). Conﬁrming the results obtained by MALDI-MSI, LA-ICP-MS reveals
that Gd concentrations in infarcted tissue increased at 6 weeks compared to 1
week after MI, representative for progressive scar formation (Fig. 6B). Similarly,
the kinetic proﬁle of gadolinium accumulation in tissue, both infarct and remote
myocardium, corresponded to the kinetics revealed by MALDI-MSI (Fig. 6C).3.5. Extracellular matrix synthesis assessment by histology
To verify the increased signal at 6 weeks gained by Gadoﬂuorine P, ECM synthesis in
the infarct scar was assessed by Elastica-Van-Gieson staining (EvG) (Fig. 7A and B).on.2018.e00606
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
Fig. 6. Quantitative Gadolinium assessment by Laser Ablation e Inductively Coupled Plasma - Mass
Spectrometry (LA-ICP-MS). A) Unstained microscopy image (left) and representative LA-ICP-MS im-
age of Gd distribution of the isotope 158Gd in the area of myocardial infarction 15 minutes after injection
with a spatial resolution/spot size, of 15 mm. (B) Dot plots show increased Gd concentration at six weeks
compared to 1 week after myocardial infarction, in infarcted tissue but also to some degree in healthy
myocardium (n ¼ 3 for 1 and n ¼ 3 for 6 weeks timepoint). C) Kinetic proﬁle of Gd accumulation
in infarcted and healthy myocardium was comparable to the results obtained by MALDI-MSI with
peak concentrations at 15 minutes after injection (n ¼ 3 per time point (in minutes) after Gd-injection).
12 https://doi.org/10.1016/j.heliy
2405-8440/ 2018 The Auth
(http://creativecommons.org/li
Article Nowe00606The mean red chromogen intensity as well as the ratio of the red stained area/all ROI
area increased signiﬁcantly at 6 weeks after MI compared to the early time point at 1
week, representing an increasing ECM synthesis content during myocardial scar for-
mation (p¼ 0.0014 and p< 0.0001, Fig. 7C and D). Thus, the increased MRI signal
for Gadoﬂuorine P was conﬁrmed by an increase in ECM synthesis on histology.Fig. 7. Assessment of extracellular matrix synthesis. A) Elastica-van-Gieson staining of myocardial
infarction at 1 week and B) at 6 weeks (scale bar is 50 mm). C) Comparison of Mean Red Intensity
in EvG Staining of myocardial infarction after 1 (n ¼ 9) and 6 (n ¼ 12) weeks shows increase in extra-
cellular matrix during progressive scar formation (p ¼ 0.0014). D) Comparison of the ratio Stained Area/
Area all ROI in EvG staining of myocardial infarction after 1 (n ¼ 9) and 6 (n ¼ 12) weeks similarly
shows increase of extracellular matrix at 6 weeks post MI (p < 0.0001). * indicates p-value < 0.05.
on.2018.e00606
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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To evaluate the relationship of ECM synthesis during scar formation and associated
cardiac function, CINE imaging was additionally performed. R1 values in infarcted
myocardium after the injection of Gadoﬂuorine P as well as MALDI-MSI results for
Gadoﬂuorine P concentration were thus correlated to the left ventricular function.
While there was no correlation observed between R1 values (r
2 ¼ 0.01, p ¼
0.901) and Gadoﬂuorine P concentration (r2 ¼ 0.19, p ¼ 0.466) at 1 week post
MI (Fig. 8A), 6 weeks after MI a positive correlation was seen between R1 values
and the ejection fraction (EF) (r2 ¼ 0.65, p ¼ 0.097). Interestingly the local Gado-
ﬂuorine P concentrations at 6 weeks demonstrated an even higher correlation with
the EF compared to the R1 values (r
2 ¼ 0.89, p ¼ 0.014) (Fig. 8B).4. Discussion
In the current study, we establish a combined MR and MSI approach to study Gado-
ﬂuorine P deposition during scar formation in a mouse model of myocardial infarc-
tion. We attribute the signal increase of Gadoﬂuorine P to post-MI scar formationFig. 8. Correlation of Gadoﬂuorine P enhancement with left-ventricular function at 1 and 6 weeks post
myocardial infarction. Correlation of R1 values (ﬁrst row; n ¼ 5) as well as tissue concentrations of Ga-
doﬂuorine P (second row) at 1 week (n ¼ 5) (Panel A) and 6 weeks (n ¼ 5) (Panel B) after MI for
infarcted myocardium with the corresponding ejection fraction.
on.2018.e00606
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enhancement and tissue concentrations have a markedly improved ejection fraction
at six weeks post MI. The signal increase detected in vivo at six weeks by MRI is
accompanied by an increase in Gadoﬂuorine P-concentration in tissue as determined
by MALDI-MSI and LA-ICP-MS.
Precise quantiﬁcation of the imaging signal is important to track the process of
myocardial healing as well as to assess the response to therapy. Quantiﬁcation of
the MRI signal in vivo is still considered the Achilles’ heel of modern MRI [17,
18]. SNR/CNR both depend on imaging parameters (e.g. inversion time, ﬂip angle)
and hardware settings (e.g. receiver gain), and thus are not quantitative. T1 mapping-
approaches allow a semi-quantitative assessment of signal enhancement by calcu-
lating the T1 value for each pixel [19]. This is semi-quantitative because the signal
observed in vivo depends on multiple factors of the local environment such as pH,
temperature, or compartmentalization of the contrast agent. Additionally, targeted
contrast agents modify their chemical structure, molecular weight and tumbling
rate once bound to speciﬁc biomarkers. Thus measuring the local concentration of
such a contrast agent depends both on the free and bound fraction of the contrast
agent which is a challenging task in vivo [20]. Methods determining actual probe
concentration in tissue post imaging would be valuable to better judge and improve
in vivo imaging results.
Gadoﬂuorine P has been developed from its precursor substance Gadoﬂuorine M.
Gadoﬂuorine M has been shown to bind to ECM proteins such as collagen, tenascin
and proteoglycans of the vessel wall in various animal models of atherosclerosis [14,
21, 22, 23, 24]. These ECM proteins can also be found in scar tissue after myocardial
infarction. Here we focused on Gadoﬂuorine P due to its favorable kinetic proﬁle. It
should be noted however that binding constants of Gadoﬂuorine P for speciﬁc extra-
cellular matrix components have yet to be reported, but - as an amphiphilic agent
similar in structure to Gadoﬂuorine M - it is expected to bind to proteins and ﬁla-
ments of the ECM due to diﬀerent surface charges. Of note, we observed quite
some variation of R1 values at 6 weeks post MI both for Gd-DTPA and Gadoﬂuorine
P. This may be due to a physiological variation of the healing response but also
reﬂect the spatial heterogeneity of healing.
Healing of myocardial infarction in mice has been shown to occur in a biphasic
manner [25]. After 1 week the process of myocardial remodeling is still at its begin-
ning, while at the later time points synthesis of extracellular matrix, formation of scar
tissue and restructuring of elastic ﬁbers has already led to a signiﬁcant rearrangement
of the left ventricle [8, 26]. Gadoﬂuorine P-signal intensity and tissue concentration
in the infarct scar correlate with ejection fraction in the course at 6 weeks after MI,
indicating that T1 mapping with MRI shows promise for correlating ECM deposi-
tion in the infarct zone with cardiac function during infarct healing.on.2018.e00606
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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and Gadoﬂuorine P tissue concentrations. This may have several reasons. First, these
correlations were not performed on a pixel-by-pixel comparison. This is hardly
possible as tissue preparation of the MALDI-MSI slides leads to changes in tissue
shape, e.g. through drying and shrinkage. Additionally, MALDI-MSI is performed
on slides with 12 mm thickness, while the slide thickness in MRI was 1mm. There-
fore, ROI-based analysis has to be performed. But more importantly, the only mod-
erate correlations demonstrate the weakness of in vivo MRI: the insuﬃciency to
provide quantitative molecular imaging data. Diﬀerent biological as well as chemical
surroundings of the probe signiﬁcantly aﬀect the signal in vivo, leading to reduction
in correlation between the measured MRI signal and the actual concentration of the
contrast agent. These confounders are unavoidable and emphasize the need to bridge
the gap towards quantiﬁcation, which we show to be feasible by MSI. Niehoﬀ et al.
recently proposed to calculate a conversion function from R1 and concentration
values and to subsequently determine in vivo contrast agent concentration maps
from T1 maps mathematically [27]. Based on the correlation of data obtained by
MRI and Mass Spectrometry Imaging, the calibration of contrast-enhanced MRI ex-
periments by spatially resolved mass spectrometry imaging is possible.
Additionally, MSI has superior resolution as compared to MRI: currently MALDI-
MSI can reach a resolution of up to 30mm, and laser ablation-inductively coupled
plasma-mass spectrometry (LA-ICP-MS) can provide gadolinium distribution
maps at a resolution of 15 mm [28, 29]. This resolutione approaching cellular levels
- potentially allows for more profound evaluation of target structures of molecular
and cellular gadolinium agents. With the advent of MSI, one can now match the
accumulation of speciﬁc contrast agents spatially to their cellular and molecular
surroundings.
The study has several limitations: 1) Exact co-registration of MRI T1 maps and gad-
olinium distribution maps has not been possible due to the experimental setup,
diﬀerent slice thicknesses and voxel size. 2) Although a promising technology,
MALDI-MSI has the drawback that on the one hand the signal is dependent on
the overlying matrix. On the other hand, the spatial resolution of MALDI-MSI
does not reach the cellular range. LA-ICP-MS, as additionally shown, is based on
elemental mass spectrometry imaging detecting total Gd in tissue, shows only little
matrix dependency and provides accurate, spatially resolved quantitative data. Addi-
tionally, LA-ICP-MS can reach a resolution of down to 5 microns, so that LA-ICP-
MS might become a valuable complementary method to MALDI-MSI. 3) Gado-
ﬂuorine P creates higher R1 values in the blood compared to the infarct region, which
is not optimal for molecular MRI of cardiac tissue. 4) The small sample size of this
experimental pilot study allows only for preliminary conclusions. Especially exper-
iments correlating contrast agent concentration to signal enhancement will have to
be performed in larger cohorts.on.2018.e00606
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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Spectrometry Imaging. MSI enables to quantify the accumulation of Gadoﬂuorine P
directed towards extracellular matrix proteins during myocardial scar formation.
Quantitative values of gadolinium in tissue provided at high spatial resolution is
beneﬁcial for validation of in vivo molecular imaging and development of future im-
aging biomarkers.Declarations
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